In The News

You are here

Dr. Greenfield Awarded Grant for Research on How Low-Grade Pediatric Tumors Transform Into Malignancies

Dr. Jeffrey Greenfield has been awarded a $75,000 grant from the Matthew Larson Foundation to support his research into how low-grade tumors are transformed into high-grade gliomas through the involvement of bone-marrow-derived cells (BMDCs). Read more about Dr. Greenfield's research.

Dr. Kaplitt Discusses Gene Therapy for Parkinson's Disease on CBS This Morning

Dr. Kaplitt appeared on CBS This Morning to discuss exciting results reported regarding gene therapy for Parkinson's disease. Dr. Kaplitt, who pioneered testing gene therapy for Parkinson's disease, talks about how gratifying it is to see real-world results emerge from his initial testing.

Dr. Schwartz Brings Endoscopic Skull Base Surgery to China

Theodore H. Schwartz, MD, director of the Pituitary and Anterior Skull Base Surgery Program at the Weill Cornell Brain and Spine Center, recently spent four days in Shanghai, helping Chinese neurosurgeons develop their skills in minimally invasive endoscopic surgery.

Brainstorm: A comeback after Chiari surgery

In the spring 2012 issue of Weill Cornell Medicine, Dr. Jeffrey Greenfield talks about his patient Connor Ventura, and about diagnosing, treating, and seeking new options for Chiari malformation.

Milestone Clinical Trial for DIPG Approved

Dr. Mark Souweidane, Weill Cornell Brain and Spine Center

Dr. Mark Souweidane, Director of Pediatric Neurological Surgery, has received FDA approval for a clinical trial for young patients diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG).